DSS (3% w/v) was added to the drinking water of
DR3−/− (n=25) and WT DR3+/+ (n=20)
mice for 7 days. A, Increased mortality, and B, increased loss of body weight in
DR3−/− compared to WT littermates. C-F,
Significant differences between DR3−/− and WT mice
were observed by day 7 post-DSS administration, but not day 21, in mean fecal
bleeding index scores (C), stool consistency scores (D), disease activity index
scores (E), and total inflammatory score (F), calculated by adding the values
for individual semi-quantitative histological scoring indices for %
ulceration, % re-epithelialization, and active, chronic, and transmural
inflammation. G, Representative H&E-stained sections depict the
histologic characteristics of colonic tissues from
DR3−/− and WT mice, with and without induction of
DSS-colitis. DR3−/− mice at day 7 show almost
complete loss of the epithelium, with increased infiltration of inflammatory
cells in the lamina propria (left middle panel); by comparison WT
DR3+/+ mice at day 7 still maintain cryptal architecture with
slightly decreased inflammatory cells in laminar propria (right middle panel).
DR3−/− and WT mice at day 21 show comparable
severity of colitis (left and right lower panels).
Original magnification of photomicrographs, 20x. H, Total RNA was
extracted from colonic specimens of DSS-treated
DR3−/− and WT DR3+/+ mice. Mucosal
mRNA expression of the indicated factors was quantified by real-time PCR. The
relative expression of each target gene was normalized to the relative
expression of GAPDH in the same sample. All data presented as mean ±
SEM; *P < 0.05, **P < 0.01, ***P < 0.001.